Back to results
US 2023/0071165 A1Published application
Pharmaceutical syrup formulation or suspension
AssigneeGenexa Inc.
InventorsMax Spielberg, David Johnson
Life of this patent
Estimating the term…
Abstract
A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
Claims25
A pharmaceutical syrup formulation for oral administration comprising:
- acetaminophen,
- agave syrup, and
- a dilutant,
- wherein the syrup formulation has a viscosity of less than 1500 centipoise at about 22 degrees;
- the acetaminophen is suspended in the syrup;
- and the syrup is palatable.
3 more elements
A stable pharmaceutical syrup formulation for oral administration comprising:
- acetaminophen;
- agave syrup;
- acidic preservative;
- a flavoring agent, and a dilutant, wherein the syrup formulation has a viscosity of less than 1500 centipoise at about 22 degrees and the acetaminophen is suspended in the syrup.
1 more element
A stable, palatable pharmaceutical syrup formulation for oral administration consisting essentially of a therapeutic effective amount of acetaminophen;
- agave syrup;
- acidic preservative;
- a flavoring agent, and a dilutant, wherein the syrup formulation has a viscosity of less than 1500 centipoise at about 22 degrees and the acetaminophen is suspended in the syrup.
Dependencies are inferred from the claim text.